T2C2 Capital
North America, Quebec, Canada, Montréal
Description
T2C2 (Technology, Transfer, Commercialisation, Capital) has the mission to identify in Universities, Research Centres and Industry,
Investor Profile
T2C2 Capital has made 4 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series B (75%)
- Series C (25%)
Country Focus
- Canada (50%)
- Israel (25%)
- France (25%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Biopharma
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
